TWiV 800: COVID-19 clinical update #78 with Dr. Daniel Griffin

In COVID-19 clinical update #78, Daniel Griffin covers ivermectin, convalescent plasma, disease in pregnant women, children and COVID, delta outbreak in an elementary school, validation of at-home antigen test, shedding in infected vaccinated people, mRNA vaccine antibody responses compared, AZD7442, fluvoxamine, one year outcomes in hospitalized patients, and post-vaccination disease. Hosts: Daniel Griffin and Vincent Racaniello Subscribe (free): iTunes, Google Podcasts, RSS, email Become a patron of TWiV! Links for this episode Do not take veterinary ivermectin (FDA) Ivermectin side effects (CDC) Do not use convalescent plasma (IDSA) COVID-19 in pregnant women (JAMA) Children and COVID-19 data (AAP) Long COVID in 11-17 year olds (Res Square) Delta outbreak elementary school (MMWR) Validation of at-home antigen test (JAMA) Shedding in infected vaccinated people (medRxiv) Compared antibody responses after mRNA vaccination (JAMA) AZD7442 PROVENT phase III (AZ) Fluvoxamine trial (medRxiv) One-year outcomes hospital survivors (Lancet) Post-vaccination illness (Lancet) Letters read on TWiV 800 Timestamps by Jolene. Thanks! Intro music is by Ronald Jenkees Send your questions for Dr. Griffin to [email protected]